Interestingly, APP/Go protein Gbeta/gamma-complex signaling was reported to mediate β-amyloid-dependent neuronal degeneration in hippocampal neurons of mice models, implying that the complex may be a promising target for therapeutic interventions in AD (Bignante et al., 2018). This evidence concerns the gene APP and Alzheimer disease.